EMT-induced metabolite signature identifies poor clinical outcome

por Bhowmik, Salil Kumar, Ramirez-Peña, Esmeralda, Arnold, James Michael, Putluri, Vasanta, Sphyris, Nathalie, Michailidis, George, Putluri, Nagireddy, Ambs, Stefan, Sreekumar, Arun, Mani, Sendurai A.
Publicado 2015

Pathway-Centric Integrative Analysis Identifies RRM2 as a Prognostic Marker in Breast Cancer Associated with Poor Survival and Tamoxifen Resistance()()()

por Putluri, Nagireddy, Maity, Suman, Kommangani, Ramakrishna, Creighton, Chad J., Putluri, Vasanta, Chen, Fengju, Nanda, Sarmishta, Bhowmik, Salil Kumar, Terunuma, Atsushi, Dorsey, Tiffany, Nardone, Agostina, Fu, Xiaoyong, Shaw, Chad, Sarkar, Tapasree Roy, Schiff, Rachel, Lydon, John P., O’Malley, Bert W., Ambs, Stefan, Das, Gokul M., Michailidis, George, Sreekumar, Arun
Publicado 2014

Methionine-Homocysteine Pathway in African-American Prostate Cancer

por Gohlke, Jie H, Lloyd, Stacy M, Basu, Sumanta, Putluri, Vasanta, Vareed, Shaiju K, Rasaily, Uttam, Piyarathna, Danthasinghe Waduge Badrajee, Fuentes, Hunter, Rajendiran, Thekkelnaycke M, Dorsey, Tiffany H, Ambati, Chandrashekar R, Sonavane, Rajni, Karanam, Balasubramanyam, Bhowmik, Salil Kumar, Kittles, Rick, Ambs, Stefan, Mims, Martha Pritchett, Ittmann, Michael, Jones, Jeffrey A, Palapattu, Ganesh, Putluri, Nagireddy, Michailidis, George, Sreekumar, Arun
Publicado 2019